Radiomics Profiling Identifies the Incremental Value of MRI Features beyond Key Molecular Biomarkers for the Risk Stratification of High-Grade Gliomas

Figure 7

Stratified Kaplan–Meier curves based on different clinical subgroups (younger or older, male or female, and GBM or non-GBM) and molecular subgroups (IDH mutation or wild-type, MGMT promoter methylation or nonmethylation) in (a) training set and (b) validation set.